secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pulmatrix, Inc. (PULM)
CIK:        0001574235
Form:       8-K
Filed at:   2024-11-13T23:59:59+00:00
Accession:  0001493152-24-044986
Event type: m_and_a
Sentiment:  negative
Materiality: 1.00
Item codes: 1.01, 5.01, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pulmatrix to merge with Cullgen in reverse merger; Cullgen holders to own 96.4%
-------------------------------------------------------------------------------

- Pulmatrix to merge with Cullgen; exchange ratio implies Cullgen valuation of $280M, Pulmatrix $10.5M.
- Pre-merger Cullgen stockholders to own ~96.4% of combined company; Pulmatrix stockholders ~3.6%.
- Pulmatrix plans cash dividend to pre-merger stockholders if net cash exceeds $2.5M at closing.
- Combined company board: eight members, seven from Cullgen, one from Pulmatrix.
- Closing conditions include stockholder votes, Nasdaq listing, SEC S-4 effectiveness, CSRC approval.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1574235/000149315224044986/0001493152-24-044986-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1574235/000149315224044986/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-044986

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer